EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Diagnosis and management of invasive fungal infections due to non- Aspergillus moulds

C Orla Morrissey iD

Journal of Antimicrobial Chemotherapy · 14.03.2025 · 80 (Supplement_1) · i17-i39

DOI: 10.1093/jac/dkaf005 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 14.03.2025. Verfasst von C Orla Morrissey. Beteiligte Einrichtung: Department of Infectious Diseases, Alfred Health, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Invasive Fungal Infections, Antifungal Agents, Fungi. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 168 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: F2G Ltd and Shionogi B.V..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Invasive fungal infection (IFI) due to moulds other than Aspergillus are a significant cause of morbidity and mortality. Non-Aspergillus mould (NAM) infections appear to be on the increase due to an ever-expanding population of immunocompromised hosts. In this review, Mucorales, Scedosporium species, Lomentospora prolificans and Fusarium species are examined in detail, and the microbiology, risk factors, diagnosis and treatment of emerging NAMs such as Paecilomyces variotti, Purpureocillium lilacinum and Rasamsonia are summarized. The challenges in diagnosis are emphasized and the emerging importance of molecular methods is discussed. Treatment of IFI due to NAMs is a multi-pronged and multi-disciplinary approach. Surgery, correction of underlying risk factors, and augmentation of the host immune response are as important as antifungal therapy. Many of these NAMs are intrinsically resistant to the currently licensed antifungal agents, so selection of therapy needs to be guided by susceptibility testing. There are new antifungal agents in development, and these have the potential to improve the efficacy and safety of antifungal treatment in the future. Ongoing research is required to fully delineate the epidemiology of NAM infections, and to develop better diagnostic tools and treatments so that outcomes from these infections can continue to improve.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Invasive Fungal InfectionsAntifungal AgentsFungiHumansImmunocompromised HostRisk FactorsDisease Management

Substanzen

Antifungal Agents

Autor:innen und Institutionen

  • Department of Infectious Diseases, Alfred Health, Melbourne, Victoria, Australia.
  • Department of Infectious Diseases, School of Translational Medicine, Monash University, Melbourne, Victoria, Australia.

ORCID-Profile: C Orla Morrissey

Förderung

  • F2G Ltd and Shionogi B.V.

Zitieren

APA

Morrissey, C. O. (2025). Diagnosis and management of invasive fungal infections due to non- Aspergillus moulds. Journal of Antimicrobial Chemotherapy, 80(Supplement_1), i17-i39. https://doi.org/10.1093/jac/dkaf005

Vancouver

Morrissey CO. Diagnosis and management of invasive fungal infections due to non- Aspergillus moulds. Journal of Antimicrobial Chemotherapy. 2025;80(Supplement_1):i17-i39. doi:10.1093/jac/dkaf005

BibTeX
@article{Morrissey2025,
  author = {Morrissey, C Orla},
  title = {Diagnosis and management of invasive fungal infections due to non- Aspergillus moulds},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2025},
  volume = {80},
  number = {Supplement_1},
  pages = {i17--i39},
  doi = {10.1093/jac/dkaf005}
}
Kostenlos starten →